Objective To determine how additional explanatory text (context) about drug side effects in a patient medication information handout affected comprehension and perceptions of risk and efficacy. Methods We conducted an online experiment with a national sample of 1,119 U.S. adults with rheumatoid arthritis and related conditions, sampled through random-digit dialing, address-based sampling, and online ads. We randomized participants to receive one of several versions of a patient information handout for a fictitious drug, either with or without additional context, then measured comprehension and other outcomes. Results Additional qualitative context about warnings and side effects resulted in lower comprehension of side effect information, but not information about uses of the drug or warnings. The effect of additional context on risk perceptions depended on whether the medication handout was delivered online or through the mail. Those who received a hardcopy of the handout with additional context had higher perceived risk of side effects than those who saw the version without additional context. Conclusion More clarifying information is not always better and may lead to cognitive overload, inhibiting comprehension. Practice implications Additional research should further explore effects of context in online vs. hard-copy formats before practice implications can be determined.
Effects of additional context information in prescription drug information sheets on comprehension and risk and efficacy perceptions
Kelly, B., O'Donoghue, A., Parvanta, S., Boudewyns, V., Oguntimein, O., Bann, C., West, S., Tzeng, J., Chandler, C., Madson, G., & McCormack, L. (2022). Effects of additional context information in prescription drug information sheets on comprehension and risk and efficacy perceptions. Journal of Pharmaceutical Policy and Practice, 15(1), . https://doi.org/10.1186/s40545-021-00386-9
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Epigenetic biomarkers for smoking cessation
A pilot PT scheme for external assessment of laboratory performance in testing synthetic opioid compounds in urine, plasma, and whole blood